Pharmacology Research
Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.
Showing 451-460 of 639 results
5-Fluorouracil reduces the fibrotic scar via inhibiting matrix metalloproteinase 9 and stabilizing microtubules after spinal cord injury
CNS Neurosci Ther, 2022 • July 1, 2022
This study investigated the effect of 5-FU on fibrotic scar formation after SCI, finding that it reduces scarring by inhibiting MMP9 and stabilizing microtubules. The study demonstrates that 5-FU admi...
KEY FINDING: 5-FU administration after spinal cord injury improved hind limb sensorimotor function.
Editorial: Advanced neural stem cell therapies for spinal cord injury
Frontiers in Pharmacology, 2024 • August 6, 2024
This editorial provides an overview of the current research landscape regarding advanced neural stem cell therapies for spinal cord injury (SCI). It summarizes key articles published on the topic, hig...
KEY FINDING: Stem cell therapy, particularly using Mesenchymal Stem Cells (MSCs) and Neural Stem Cells (NSCs), shows promise for treating SCI, although firm evidence of a cure is lacking.
Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats
Frontiers in Cellular Neuroscience, 2022 • August 22, 2022
This study found that stress-induced visceral hypersensitivity is linked to downregulated 5-HT1ARs, which in turn enhances ACC theta oscillations. Tandospirone (TDS) was found to alleviate both viscer...
KEY FINDING: Tandospirone (TDS) ameliorated visceral hypersensitivity and anxiety-like behavior induced by water avoidance stress.
Direct Potential Modulation of Neurogenic Differentiation Markers by Granulocyte-Colony Stimulating Factor (G-CSF) in the Rodent Brain
Pharmaceutics, 2022 • September 2, 2022
This study investigates the molecular effects of a single subcutaneous high-dose G-CSF application upon different regions of the rodent brain. The study reveals minor suppressive or stimulatory effect...
KEY FINDING: G-CSF generally downregulates neurogenic differentiation markers in most brain regions studied.
DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery
Genomics Proteomics Bioinformatics, 2022 • September 29, 2022
The study introduces DrSim, a learning-based framework designed to infer similarity between transcriptional profiles for phenotypic drug discovery, addressing limitations of traditional unsupervised m...
KEY FINDING: DrSim outperforms existing methods in drug annotation, showing higher accuracy in predicting the mechanisms of action (MOAs) of compounds.
Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology
Disease Markers, 2022 • October 4, 2022
This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects fro...
KEY FINDING: 164 potential active compounds from XCHD were screened to act on 95 HF-related targets.
The Effect of Amniotic Tissue on Spinal Interventions: A Systematic Review
International Journal of Spine Surgery, 2022 • October 12, 2022
This systematic review summarizes the existing literature regarding the use of amniotic membrane preparations, treatment regimens, and indications within spinal surgery. The review of reported studies...
KEY FINDING: Amnion products show promising effects in reducing epidural adhesions and scar tissue after spine surgery.
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury
Neural Regeneration Research, 2023 • May 1, 2023
Spinal cord injury results in the loss of functional mobility, sensations, and neuromuscular and skeletal function. Injury can lead to apoptosis of the neurons and degradation of oligodendrocytes caus...
KEY FINDING: Clemastine enhances oligodendrocyte differentiation and myelination, which helps to delay axonal degeneration and promote motor function recovery in rat SCI models.
Andrographolide contributes to spinal cord injury repair via inhibition of apoptosis, oxidative stress and inflammation
Frontiers in Pharmacology, 2022 • October 7, 2022
This study investigated the neuroprotective effects of Andrographolide (Andro) on spinal cord injury (SCI) in rats. The findings suggest that Andro treatment can alleviate SCI by reducing apoptosis, o...
KEY FINDING: Andro treatment significantly improved tissue repair and functional recovery after SCI by reducing apoptosis, oxidative stress, and inflammation through the Nrf-2/HO-1 and NF-κB signaling pathways.
Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review
Orthopaedic Surgery, 2022 • December 1, 2022
This review synthesizes current research on resveratrol's (RSV) effects on intervertebral disc degeneration (IDD). It highlights RSV's potential to address the limitations of current IDD treatments by...
KEY FINDING: RSV exhibits anti-inflammatory effects by inhibiting pro-inflammatory cytokines like IL-1β, IL-6, IL-8, and TNF-α, which ameliorates IDD progression mediated by inflammation.